Board of Governors
CancerLinQ is governed by a volunteer Board of Governors elected by its sole member, the American Society of Clinical Oncology. The CancerLinQ Chief Executive Officer serves on the Board as well. Board members are not paid for their service, although they receive reimbursement for direct expenses related to the conduct of their Board duties.
View the Disclosures for the Board of Governors below each individual’s name. Please direct any questions related to Board members' disclosures to COI@asco.org.
-
Carmen Jackson, PMP
Interim CEO, CancerLinQ
-
Clifford A. Hudis, MD, FACP, FASCO, CEO, Chair
ASCO
View Disclosure
-
Ronald Andrews
OncoCyte
View Disclosure
-
Howard Burris III, MD, FACP, FASCO
Sarah Cannon
View Disclosure
-
Eric P. Winer, MD, FASCO
Yale Cancer Center
View Disclosure
-
Aaron Sasson
Lanetix
-
Robin Zon, MD, FACP, FASCO
Michiana Hematology Oncology
View Disclosure